云芝与节拍式唑来膦酸联用在小鼠乳腺癌胫骨内模型中的评价
本研究在胫骨内接种人乳腺癌细胞的小鼠模型中,评估云芝水提物与节拍式唑来膦酸(mZOL)联用4周对肿瘤生长、转移和骨破坏的影响。结果显示联用可减小肿瘤生长、保护骨完整性,且未增加肺和肝转移发生率;体外实验证实联用抑制癌细胞增殖和破骨细胞生成。
要点
- 云芝与mZOL联用可减小胫骨内乳腺癌小鼠的肿瘤生长。
- 联用未增加肺和肝转移的发生率,并保护骨完整性。
- 体外实验显示联用抑制癌细胞增殖和破骨细胞生成。
核心结论
- 云芝与mZOL联用可减轻乳腺肿瘤进展、保护骨免受溶骨性病变,且未见显著转移。
研究设计与样本
- 小鼠胫骨内接种表达荧光素酶的人乳腺癌细胞MDA-MB-231-TXSA,分别给予云芝水提物、mZOL或两者联用4周。
- 采用IVIS成像系统定量胫骨、肝和肺的荧光素酶信号,并用micro-CT评估骨骼反应。
- 进行体外实验以验证体内发现。
主要发现
- 联用云芝与mZOL减小肿瘤生长,且未增加肺和肝转移的发生率。
- 联用治疗保留了骨完整性。
- 体外研究表明联用云芝与mZOL抑制癌细胞增殖和破骨细胞生成。
临床怎么用
- 本研究提示云芝与mZOL联用可能作为乳腺癌及其转移管理的辅助策略,但尚未提供临床推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Coriolus versicolor (CV) is a mushroom traditionally used for strengthening the immune system and nowadays used as immunomodulatory adjuvant in anticancer therapy. Breast cancer usually metastasizes to the skeleton, interrupts the normal bone remodeling process and causes osteolytic bone lesions. The aims of the present study were to evaluate its herb-drug interaction with metronomic zoledronate in preventing cancer propagation, metastasis and bone destruction. MATERIALS AND METHODS: Mice inoculated with human breast cancer cells tagged with a luciferase (MDA-MB-231-TXSA) in tibia were treated with CV aqueous extract, mZOL, or the combination of both for 4 weeks. Alteration of the luciferase signals in tibia, liver and lung were quantified using the IVIS imaging system. The skeletal response was evaluated using micro-computed tomography (micro-CT). In vitro experiments were carried out to confirm the in vivo findings. RESULTS: Results showed that combination of CV and mZOL diminished tumor growth without increasing the incidence of lung and liver metastasis in intratibial breast tumor model. The combination therapy also reserved the integrity of bones. In vitro studies demonstrated that combined use of CV and mZOL inhibited cancer cell proliferation and osteoclastogenesis. CONCLUSIONS: These findings suggested that combination treatment of CV and mZOL attenuated breast tumor propagation, protected against osteolytic bone lesion without significant metastases. This study provides scientific evidences on the beneficial outcome of using CV together with mZOL in the management of breast cancer and metastasis, which may lead to the development of CV as adjuvant health supplement for the control of breast cancer.
引用
- Ko CH, Yue GG, Gao S, et al. Evaluation of the combined use of metronomic zoledronic acid and Coriolus versicolor in intratibial breast cancer mouse model. J Ethnopharmacol. 2017. PMID: 28412218. doi:10.1016/j.jep.2017.04.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。